Regenerative Medicine Clinical-Trial Glossary: jRCT, Phase I/II, Eligibility, Endpoints, and Conditional Approval
为中文患者和家属解释日本再生医疗临床试验常见词：jRCT、募集状态、I/II期、入选排除标准、主要终点、不良事件、条件及期限承认。
再生医疗
Japan’s Regenerative Medicine Enters the Stage of Clinical Implementation: iPS Approvals, Conditional and Time-Limited Approval, and the Boundaries of Patient Expectations
从 AMCHEPRY、Heartseed HS-005 和 PMDA 条件期限承认制度，看日本 iPS 再生医疗为什么值得关注，也为什么必须谨慎解读。